Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 5
1981 8
1982 37
1983 17
1984 26
1985 19
1986 23
1987 29
1988 32
1989 39
1990 39
1991 59
1992 74
1993 77
1994 103
1995 129
1996 109
1997 143
1998 215
1999 222
2000 206
2001 225
2002 243
2003 242
2004 234
2005 267
2006 231
2007 249
2008 257
2009 252
2010 256
2011 266
2012 278
2013 235
2014 280
2015 289
2016 290
2017 300
2018 309
2019 302
2020 369
2021 382
2022 346
2023 322
2024 282

Text availability

Article attribute

Article type

Publication date

Search Results

7,635 results

Results by year

Filters applied: . Clear all
Page 1
Reviewing the therapeutic role of budesonide in Crohn's disease.
López-Sanromán A, Clofent J, Garcia-Planella E, Menchén L, Nos P, Rodríguez-Lago I, Domènech E. López-Sanromán A, et al. Gastroenterol Hepatol. 2018 Aug-Sep;41(7):458-471. doi: 10.1016/j.gastrohep.2018.05.013. Epub 2018 Jul 12. Gastroenterol Hepatol. 2018. PMID: 30007787 Free article. Review. English, Spanish.
Oral budesonide is a glucocorticoid of primarily local action. In the field of digestive diseases, it is used mainly in inflammatory bowel disease, but also in other indications. This review addresses the pharmacology, pharmacodynamics and therapeutic use of budesonide …
Oral budesonide is a glucocorticoid of primarily local action. In the field of digestive diseases, it is used mainly in inflammatory …
Editorial.
Toskala E. Toskala E. Int Forum Allergy Rhinol. 2017 May;7(5):439-440. doi: 10.1002/alr.21947. Int Forum Allergy Rhinol. 2017. PMID: 28493305 No abstract available.
Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management.
Daley-Yates P, Singh D, Igea JM, Macchia L, Verma M, Berend N, Plank M. Daley-Yates P, et al. Adv Ther. 2023 Sep;40(9):4042-4059. doi: 10.1007/s12325-023-02585-z. Epub 2023 Jul 12. Adv Ther. 2023. PMID: 37438554 Free PMC article. Review.
This article reviews efficacy versus systemic activity profiles for various adherence patterns and dosing regimens of fluticasone furoate (FF)-containing and budesonide (BUD)-containing asthma therapies in clinical trials and real-world studies. METHODS: We performed a str …
This article reviews efficacy versus systemic activity profiles for various adherence patterns and dosing regimens of fluticasone furoate (F …
Budesonide bests COVID-19.
Moe SS, Allan GM, Train A. Moe SS, et al. Can Fam Physician. 2022 May;68(5):355. doi: 10.46747/cfp.6805355. Can Fam Physician. 2022. PMID: 35552214 Free PMC article. No abstract available.
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials.
Bafadhel M, Peterson S, De Blas MA, Calverley PM, Rennard SI, Richter K, Fagerås M. Bafadhel M, et al. Lancet Respir Med. 2018 Feb;6(2):117-126. doi: 10.1016/S2213-2600(18)30006-7. Epub 2018 Jan 10. Lancet Respir Med. 2018. PMID: 29331313 Clinical Trial.
METHODS: We analysed data from three AstraZeneca randomised controlled trials of budesonide-formoterol in patients with COPD with a history of exacerbations and available blood eosinophil counts. ...Only eosinophil count and smoking history were independent predictors of r …
METHODS: We analysed data from three AstraZeneca randomised controlled trials of budesonide-formoterol in patients with COPD with a h …
Acute pancreatitis in an ulcerative colitis patient treated with vedolizumab and budesonide.
Ravn CD, Bendix M, Lyhne S. Ravn CD, et al. Ugeskr Laeger. 2024 May 27;186(22):V01240025. doi: 10.61409/V01240025. Ugeskr Laeger. 2024. PMID: 38847300 Free article. Danish.
Vedolizumab is a human monoclonal antibody with gut-selective integrin antagonist effect, and it is used for treatment of inflammatory bowel disease (IBD). Budesonid is a glucocorticoid which is released in the colon and it is also used in IBD treatment. This is a case rep …
Vedolizumab is a human monoclonal antibody with gut-selective integrin antagonist effect, and it is used for treatment of inflammatory bowel …
Topical therapy.
Gross V. Gross V. Dig Dis. 2012;30 Suppl 3:92-9. doi: 10.1159/000342730. Epub 2013 Jan 3. Dig Dis. 2012. PMID: 23295698 Review.
Rectal mesalazine is more effective than rectal systemically active corticosteroids or topically active corticosteroids like budesonide. In patients with mild to moderately active distal ulcerative colitis, topical mesalazine is therefore the treatment of choice. ...In the …
Rectal mesalazine is more effective than rectal systemically active corticosteroids or topically active corticosteroids like budesonide …
7,635 results